Covaxin Vaccine for Covid 19


The world health Organisation said more information is requiring from Bharat Biotech which is seeking emergency use listing for its Covaxin vaccine for COVID-19. Then the latest status of COVID 19 vaccine with in WHO evaluation process guidance document dated May 18 on the WHO website said Bharat Biotech submitted expression of Interest on April 19. According the oath WHO submissions to for prequalification or listing under the emergency use procedure are confidential. Then if a product submitted for assessments is found to meet the criteria for listing, WHO will be publish the results.
Meanwhile Bharat Biotech International Limited has conveyed to the government that it has already submitted 90 percent of documents to WHO for obtaining emergency use listing for the Covaxin vaccine sources said on Monday. Nothing that Covaxin has already received regulatory approval from 11 countries, sources said there was also interest from other 11 companies in seven nations for technology transfer and production of Covaxin. The sources said the meeting with BBIL on the EUL was attended by the company’s managing director VK Krishna Mohan and his colleagues besides senior officers of the Ministry of Health, Department of Biotechnology and Ministry of External Affairs.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this:
search previous next tag category expand menu location phone mail time cart zoom edit close